Anna Richter

Ernst Heydemann Str. 6
Rostock, MV 18057, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 19 publications

Venetoclax and hypomethylating agents synergize to increase cell death and metabolic remodeling in acute B-lymphoblastic leukemia cells.

Venetoclax and hypomethylating agents synergize to increase cell death and metabolic remodeling in acute B-lymphoblastic leukemia cells.

Journal: Molecular metabolism

Published: March 05, 2026

Venetoclax and hypomethylating agents synergize to increase cell death and metabolic remodeling in acute B-lymphoblastic leukemia cells.

Venetoclax and hypomethylating agents synergize to increase cell death and metabolic remodeling in acute B-lymphoblastic leukemia cells.

Journal: Molecular metabolism

Published: March 05, 2026

Venetoclax resistance in preclinical KMT2A-rearranged acute lymphoblastic leukemia models is characterized by high inter- and intra-model heterogeneity.

Venetoclax resistance in preclinical KMT2A-rearranged acute lymphoblastic leukemia models is characterized by high inter- and intra-model heterogeneity.

Journal: NPJ precision oncology

Published: August 20, 2025

Improving pain management for murine orthotopic xenograft models of acute lymphoblastic leukemia.

Improving pain management for murine orthotopic xenograft models of acute lymphoblastic leukemia.

Journal: Lab animal

Published: March 04, 2025

Mouse strain-specific habituation to oral metamizole administration.

Mouse strain-specific habituation to oral metamizole administration.

Journal: Laboratory animals

Published: December 13, 2024

KMT2A degradation is observed in decitabine-responsive acute lymphoblastic leukemia cells.

KMT2A degradation is observed in decitabine-responsive acute lymphoblastic leukemia cells.

Journal: Molecular oncology

Published: August 30, 2024

Origin of breath isoprene in humans is revealed via multi-omic investigations.

Origin of breath isoprene in humans is revealed via multi-omic investigations.

Journal: Communications biology

Published: July 18, 2023

Combined BCL-2 and PI3K/AKT Pathway Inhibition in KMT2A-Rearranged Acute B-Lymphoblastic Leukemia Cells.

Combined BCL-2 and PI3K/AKT Pathway Inhibition in KMT2A-Rearranged Acute B-Lymphoblastic Leukemia Cells.

Journal: International journal of molecular sciences

Published: December 14, 2022

Effective tumor cell abrogation via Venetoclax-mediated BCL-2 inhibition in KMT2A-rearranged acute B-lymphoblastic leukemia.

Effective tumor cell abrogation via Venetoclax-mediated BCL-2 inhibition in KMT2A-rearranged acute B-lymphoblastic leukemia.

Journal: Cell death discovery

Published: May 09, 2022

Validation of an LC-MS/MS Method for the Quantification of the CK2 Inhibitor Silmitasertib (CX-4945) in Human Plasma.

Validation of an LC-MS/MS Method for the Quantification of the CK2 Inhibitor Silmitasertib (CX-4945) in Human Plasma.

Journal: Molecules (Basel, Switzerland)

Published: February 15, 2022

Spontaneous Hind Limb Paralysis Due to Acute Precursor B Cell Leukemia in RAG1-deficient Mice.

Spontaneous Hind Limb Paralysis Due to Acute Precursor B Cell Leukemia in RAG1-deficient Mice.

Journal: Journal of molecular neuroscience : MN

Published: February 01, 2022

The Molecular Subtype of Adult Acute Lymphoblastic Leukemia Samples Determines the Engraftment Site and Proliferation Kinetics in Patient-Derived Xenograft Models.

The Molecular Subtype of Adult Acute Lymphoblastic Leukemia Samples Determines the Engraftment Site and Proliferation Kinetics in Patient-Derived Xenograft Models.

Journal: Cells

Published: December 02, 2021

Showing 1-12 of 19

Last Updated: 09/26/2026